Earnings History Data for AC Immune SA (ACIU) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

AC Immune SA

AC Immune SA is a biopharmaceutical company. It develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Company's pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn which are in clinical trial. AC Immune SA is based in Lausanne, Switzerland.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
28-04-2021 PM ACIU Ac Immune Sa 511.00 -0.25 -0.21 0.00 AC Immune reports Q1 results; outlook
[4/28/2021 7:24 AM]
6.91 -0.23 
(-3.22%)
0.0 0.0 
(0.00%)
4.42 - 13.00 131,170 170,000 0
23-03-2021 PM 7:00 AM ET
(Mar 23)
ACIU Ac Immune Sa 572.00 -0.30 -0.29 0.00 AC Immune EPS misses by CHF0.02, misses on revenue; outlook
[3/23/2021 7:35 AM]
7.67 -0.04 
(-0.52%)
7.72 0.01 
(0.13%)
4.42 - 13.00 238,295 340,000 1,472
13-11-2020 PM ACIU Ac Immune Sa 369.00 -0.28 -0.24 0.00 AC Immune EPS misses by CHF0.02, beats on revenue
[11/13/2020 7:22 AM]
5.15 -0.03 
(-0.58%)
5.18 0.0 
(0.00%)
4.07 - 13.00 173,487 536,388 3,722